SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-022926
Filing Date
2020-02-03
Accepted
2020-02-03 16:09:09
Documents
15
Period of Report
2020-02-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848430d8k.htm   iXBRL 8-K 27793
2 EX-99.1 d848430dex991.htm EX-99.1 21455
6 GRAPHIC g848430g0203220752935.jpg GRAPHIC 4279
7 GRAPHIC g848430g0203220753154.jpg GRAPHIC 4018
  Complete submission text file 0001193125-20-022926.txt   190469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gwph-20200203.xsd EX-101.SCH 3040
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20200203_lab.xml EX-101.LAB 18062
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20200203_pre.xml EX-101.PRE 11355
11 EXTRACTED XBRL INSTANCE DOCUMENT d848430d8k_htm.xml XML 3584
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 20568721
SIC: 2834 Pharmaceutical Preparations